This free webinar provides an overview of key trends in market access for medical technologies in Europe, based on extensive consulting practice of MTRC
Market access is a relatively stable field with only some developments (e.g. introduction of Innovation and Technology Payment in England or prolongation of G-BA Innovation Fund in Germany). However, there are some major underlying trends, that shape the whole market access landscape and which require a rethinking of some of the approaches to market access. Some of these trends require close collaboration with clinical affairs and marketing.
In this free webinar, we discuss the key trends, affecting market access landscape, including a growing competition for hospital budget, disinvestment policies, therapy development vs selling devices, innovative payment schemes, value-based health care and bundled payments, enabling patients and utilizing their support.
Discussion of each trend is concluded by the key takeaways and recommendations for the Med Tech industry.
This webinar is free of charge.
Typical activities of market access function, recent changes with market access in key EU countries
Increasing financial pressure on hospitals, hospital decision-making, and factors affecting the choice of medical technologies
Value of disinvestment, Program budgeting and marginal analysis (PBMA)
Focus on the whole pathway vs end-user, the importance of referral practice
Objectives of innovation payment schemes, existing schemes in Europe, focus of the schemes (unconditional funding vs coverage with evidence development)
Outcome-based payment models, bundled payment models in Europe
The value of raising awareness among patients about a disease and available treatment options
This 1-minute extract presents discussion about the innovative payment schemes for medical technologies in Europe
Only your contact details are required to access the webinar
50% Complete
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua.